[eLong, Inc. Reports First Quarter 2009 Unaudited Financial Results BEIJING, China May 27, 2009 eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the first quarter ended March 31, 2009. Highlights Total gross revenues net revenues Travel revenues before business tax and surcharges (figures in RMB 000s;]
[AMENDMENT TO LOANOUT AGREEMENT THIS AMENDMENT TO LOANOUT AGREEMENT (“Amendment”) is made and entered into as of May 26, 2009, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and Worldwide Officers, Inc. a California Corporation (the “Lender”). Capitalized terms used herein and undefined shall have the meanings set forth in that certain Loanout Agreement (defined in the] [SKYSTAR BIO-PHARMACEUTICAL COMPANY Room 10601, Jiezuo Plaza No. 4, Fenghui Road South Gaoxin District, Xian Province People’s Republic of China May 26, 2009 Mr. Mark D. Chen Suite 10-64 #9 Jianguomenwai Avenue Beijing, P.R. China 100600 Re: Director Offer Letter Dear Mr. Chen: Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), is pleased to offer you a director position on]
[AMENDMENT TO LOANOUT AGREEMENT THIS AMENDMENT TO LOANOUT AGREEMENT (“Amendment”) is made and entered into as of May 26, 2009, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and Worldwide Officers, Inc. a California Corporation (the “Lender”). Capitalized terms used herein and undefined shall have the meanings set forth in that certain Loanout Agreement (defined in the] [SKYSTAR BIO-PHARMACEUTICAL COMPANY Room 10601, Jiezuo Plaza No. 4, Fenghui Road South Gaoxin District, Xian Province People’s Republic of China May 26, 2009 Mr. Mark D. Chen Suite 10-64 #9 Jianguomenwai Avenue Beijing, P.R. China 100600 Re: Director Offer Letter Dear Mr. Chen: Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), is pleased to offer you a director position on]
[eLong, Inc. Reports First Quarter 2009 Unaudited Financial Results BEIJING, China May 27, 2009 eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the first quarter ended March 31, 2009. Highlights Total gross revenues net revenues Travel revenues before business tax and surcharges (figures in RMB 000s;]
[Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 Investments in Infrastructure Expected To Positively Effect Performance This Year New York, New York – May 27, 2009 – Biostar Pharmaceuticals, Inc. (“Biostar” or the “Company”) (OTCBB: BSPM) today reported financial results for the three months ended March 31, 2009. The Company reported revenue of $7,447,664]
[Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 Investments in Infrastructure Expected To Positively Effect Performance This Year New York, New York – May 27, 2009 – Biostar Pharmaceuticals, Inc. (“Biostar” or the “Company”) (OTCBB: BSPM) today reported financial results for the three months ended March 31, 2009. The Company reported revenue of $7,447,664]
[CHINA NEPSTAR CHAIN DRUGSTORE LTD. Form 6-K TABLE OF CONTENTS Page 3 4 2 CHINA NEPSTAR CHAIN DRUGSTORE LTD. William Weili Dai Chief Financial Officer 3]
[CHINA NEPSTAR CHAIN DRUGSTORE LTD. Form 6-K TABLE OF CONTENTS Page 3 4 2 CHINA NEPSTAR CHAIN DRUGSTORE LTD. William Weili Dai Chief Financial Officer 3]
[CHINA SUNERGY ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2009 Nanjing, China – May 27, 2009 – China Sunergy Co., Ltd. (Nasdaq: CSUN), (“China Sunergy” or the “Company”) a specialized solar cell manufacturer based in Nanjing, China, announced today its financial results for the first quarter of 2009. First Quarter Financial Results · Revenues were US$37.0 million, a 14.4%]
[Origin Agritech Limited Reports Second Quarter Financial Results Advances from Customers for Q2 09 were RMB 165.21 million from RMB 105.17 million in Q2 08, an increase of 57.09% Deferred Revenues for Q2 09 were RMB 443.40 million from RMB 400.15 million in Q2 08, an increase of 10.80% Origin Agritech Limited (“Origin” or the “Company”) BEIJING--(BUSINESS WIRE)--May 26, 2009--]
